Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: Influence of linker length and flexibility

被引:271
作者
Reinke, Ashley A. [1 ]
Gestwicki, Jason E. [1 ]
机构
[1] Univ Michigan, Inst Life Sci, Dept Pathol, Ann Arbor, MI 48109 USA
关键词
Alzheimer's disease; neurodegeneration; protein misfolding; thioflavin T; SMALL-MOLECULE INHIBITORS; ALZHEIMERS-DISEASE; FIBRIL FORMATION; BINDING-SITES; PEPTIDE; PROTEIN; MECHANISM; OLIGOMERS; PROTOFIBRILS; POLYPHENOLS;
D O I
10.1111/j.1747-0285.2007.00557.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Self-assembly of amyloid beta into fibrillar plaques is characteristic of Alzheimer's disease and oligomers of this peptide are believed to be involved in neurodegeneration. Natural organic dyes, such as congo red and curcumin, bind tightly to amyloid beta and, at higher concentrations, block its self-assembly. The ability of these molecules to prevent amyloid accumulation has generated interest in understanding which of their structural features contribute to inhibitory potency. In general, amyloid beta ligands tend to be flat, planar molecules with substituted aromatic end groups; however, a comprehensive structure-activity study has not been reported. To better understand these ligands, we surveyed the effect of three prominent features on inhibition of amyloid aggregation: the presence of two aromatic end groups, the substitution pattern of these aromatics, and the length and flexibility of the linker region. We found that modification of any one of the modules has profound effects on activity. Further, we report that the optimal length of the linker lies within a surprisingly narrow regime (6-19 angstrom). These results offer insight into the key chemical features required for inhibiting amyloid beta aggregation. In turn, these findings help define the nature of the docking site for small molecules on the amyloid beta surface.
引用
收藏
页码:206 / 215
页数:10
相关论文
共 56 条
  • [51] Urbanc Brigita, 2006, Current Alzheimer Research, V3, P493, DOI 10.2174/156720506779025170
  • [52] Amyloid-β oligomers:: their production, toxicity and therapeutic inhibition
    Walsh, DM
    Klyubin, I
    Fadeeva, JV
    Rowan, MJ
    Selkoe, DJ
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 : 552 - 557
  • [53] Alanine scanning mutagenesis of Aβ(1-40) amyloid fibril stability
    Williams, AD
    Shivaprasad, S
    Wetzel, R
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2006, 357 (04) : 1283 - 1294
  • [54] Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo
    Yang, FS
    Lim, GP
    Begum, AN
    Ubeda, OJ
    Simmons, MR
    Ambegaokar, SS
    Chen, PP
    Kayed, R
    Glabe, CG
    Frautschy, SA
    Cole, GM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (07) : 5892 - 5901
  • [55] Delineation of positron emission tomography imaging agent binding sites on β-amyloid peptide fibrils
    Ye, L
    Morgenstern, JL
    Gee, AD
    Hong, GZ
    Brown, J
    Lockhart, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (25) : 23599 - 23604
  • [56] Structure-activity relationship of imidazo[1,2-α]pyridines as ligands for detecting β-amyloid plaques in the brain
    Zhuang, ZP
    Kung, MP
    Wilson, A
    Lee, CW
    Plössl, K
    Hou, C
    Holtzman, DM
    Kung, HF
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (02) : 237 - 243